Somanetics Corporation (NASDAQ: SMTS) focuses on developing, manufacturing and marketing the INVOS® Cerebral/Somatic Oximeter. This non-invasive patient monitoring system constantly measures changes in the blood oxygen levels in patients with or at risk for restricted blood flow. The INVOS System also provides the information necessary to identify oxygen imbalances in tissues beneath the sensor, allowing medical professionals to take corrective action. For further information, visit the Company’s web site at www.somanetics.com.
- 17 years ago
QualityStocks
Somanetics Corporation (NASDAQ: SMTS)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Micropolis Holding Co. (NYSE American: MCRP) Signs MoU with SEE Holding to Power Global Expansion of Sustainable City 2.0
Micropolis (NYSE American: MCRP), a UAE-based leader in robotics and AI, has signed a non-legally…
-
QualityStocksNewsBreaks – TransCode Therapeutics, Inc. (NASDAQ: RNAZ) Adjourns Special Meeting Due to Lack of Quorum
TransCode Therapeutics (NASDAQ: RNAZ) announced that its April 21 special meeting has been adjourned to…
-
Soligenix Inc. (NASDAQ: SNGX) HyBryte(TM) Paves Way for Breakthrough Treatment for Rare Skin Cancer
The global rare disease treatment market was estimated at $195.2 billion in 2024 and is…